Physician profile
Jamie Mieras
NPI 1871819078
$2,745.98
in general payments reported to CMS, 2019-2025
11 companies · $273 in 2025
The $273 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $911 · 2020: $1,542 · 2022: $19.07 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $1,442.00 | 2020 | |
| Smith+Nephew, INC. | $645.74 | 2019-2025 | Spatial Frame, Q-Fix |
| Stryker Corporation | $322.71 | 2019-2020 | |
| Arthrex, INC. | $79.96 | 2025 | |
| Mimedx Group, INC. | $67.30 | 2025 | |
| Integra Lifesciences Corporation | $54.31 | 2019-2025 | Tcc-Ez |
| Depuy Synthes Sales INC. | $39.19 | 2025 | Motoband |
| Zimmer Biomet Holdings, INC. | $35.81 | 2019 | |
| Tactile Systems Technology INC | $26.18 | 2025 | Nimbl, Flexitouch Plus |
| Heron Therapeutics, INC. | $19.07 | 2022 | |
| Wright Medical Technology, INC. | $13.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Mieras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.